Pneumococcal conjugate second or third-dose vaccines (PCVc) in Bolivia
Bolivia: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 59.0% in 2025. ◆ Volatile
Latest (2025)
59.0%
Change on year
unchanged
World rank
148th
of 194 countries
All-time high
87.0%
in 2016
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Bolivia, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Bolivia is 59.0%, measured in 2025.
The figure is down 31.4% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Bolivia peaked at 87.0% in 2016 and was at its lowest, 0.0%, in 2008.
That places Bolivia 148th out of 194 countries with data for 2025, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Bolivia, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 56.0% | — |
| 2015 | 86.0% | +53.6% |
| 2016 | 87.0% | +1.2% |
| 2017 | 83.0% | -4.6% |
| 2018 | 83.0% | +0.0% |
| 2019 | 75.0% | -9.6% |
| 2020 | 68.0% | -9.3% |
| 2021 | 70.0% | +2.9% |
| 2022 | 69.0% | -1.4% |
| 2023 | 68.0% | -1.4% |
| 2024 | 59.0% | -13.2% |
| 2025 | 59.0% | +0.0% |
Bolivia compared with similar countries
- Bolivia's 59.0% is below the median for lower middle income countries, which is 84.0%, 70% of the median. (47 countries reporting)
- Bolivia's 59.0% is below the median for Latin America & Caribbean, which is 82.5%, 72% of the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 47.0% | 0.0% | 87.0% | 10 |
| 2020s | 65.5% | 59.0% | 70.0% | 6 |
Countries ranked near Bolivia
- 147 North Macedonia 60.0% compare
- 148 Cote d'Ivoire 59.0% compare
- 148 Philippines 59.0% compare
- 151 Madagascar 56.0% compare
More health data for Bolivia
- Un projection of annual infant deaths, annual growth rate -2.04 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3723 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,159 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,250 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.2082 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.049 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.2019 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Bolivia?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Bolivia was 59.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Bolivia?
- The highest recorded value was 87.0% in 2016.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Bolivia?
- The lowest recorded value was 0.0% in 2008.
- How does Bolivia rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Bolivia ranks 148th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Bolivia?
- Over the last ten years it is down 31.4%. The long-run trend across the full record is volatile.
- Where does this Bolivia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).